drugset / Trial / NCT01011725

Safety, Tolerability and Efficacy of MK0773 in Healthy Postmenopausal Women (0773-003)

NCT01011725

Phase 1 Completed 67 enrolled Merck Sharp & Dohme LLC
RandomizedParallel-groupDouble-blindTreatment

Summary

This study will assess the safety, tolerability, pharmacokinetics, and pharmacodynamic efficacy of MK0773 in healthy postmenopausal women.

Timeline

Start
2005-11
Primary completion
2006-04
Completion
2009-03

Drugs

EvaluationDrugModalityDoseRoute
Subject MK0773 Other / unclassified 25 mg Oral
Subject MK0773 Other / unclassified 100 mg Oral

Indications